1. Home
  2. BIVI vs LVLU Comparison

BIVI vs LVLU Comparison

Compare BIVI & LVLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • LVLU
  • Stock Information
  • Founded
  • BIVI 2013
  • LVLU 1996
  • Country
  • BIVI United States
  • LVLU United States
  • Employees
  • BIVI N/A
  • LVLU N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • LVLU Catalog/Specialty Distribution
  • Sector
  • BIVI Health Care
  • LVLU Consumer Discretionary
  • Exchange
  • BIVI Nasdaq
  • LVLU Nasdaq
  • Market Cap
  • BIVI 18.6M
  • LVLU 18.4M
  • IPO Year
  • BIVI N/A
  • LVLU 2021
  • Fundamental
  • Price
  • BIVI $1.08
  • LVLU $0.42
  • Analyst Decision
  • BIVI Strong Buy
  • LVLU Hold
  • Analyst Count
  • BIVI 1
  • LVLU 2
  • Target Price
  • BIVI $30.00
  • LVLU $1.00
  • AVG Volume (30 Days)
  • BIVI 282.1K
  • LVLU 84.1K
  • Earning Date
  • BIVI 05-12-2025
  • LVLU 05-14-2025
  • Dividend Yield
  • BIVI N/A
  • LVLU N/A
  • EPS Growth
  • BIVI N/A
  • LVLU N/A
  • EPS
  • BIVI N/A
  • LVLU N/A
  • Revenue
  • BIVI N/A
  • LVLU $302,783,000.00
  • Revenue This Year
  • BIVI N/A
  • LVLU N/A
  • Revenue Next Year
  • BIVI N/A
  • LVLU $2.53
  • P/E Ratio
  • BIVI N/A
  • LVLU N/A
  • Revenue Growth
  • BIVI N/A
  • LVLU N/A
  • 52 Week Low
  • BIVI $0.62
  • LVLU $0.33
  • 52 Week High
  • BIVI $7.50
  • LVLU $1.95
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 53.42
  • LVLU 50.06
  • Support Level
  • BIVI $1.07
  • LVLU $0.36
  • Resistance Level
  • BIVI $1.13
  • LVLU $0.47
  • Average True Range (ATR)
  • BIVI 0.06
  • LVLU 0.04
  • MACD
  • BIVI 0.00
  • LVLU 0.00
  • Stochastic Oscillator
  • BIVI 65.99
  • LVLU 56.73

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About LVLU Lulu's Fashion Lounge Holdings Inc.

Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.

Share on Social Networks: